• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病视网膜病变筛查对新诊断 2 型糖尿病患者的成本效益:一项全国范围内基于倾向评分匹配队列研究。

Cost-effectiveness of diabetic retinopathy screening for newly diagnosed type 2 diabetic patients: A nationwide population-based propensity score-matched cohort study.

机构信息

Department of Ophthalmology, Fu Jen Catholic University Hospital, Fu Jen Catholic University, New Taipei City, Taiwan; Graduate Institute of Business Administration, Fu Jen Catholic University, New Taipei City, Taiwan.

Artificial Intelligence Development Center, Fu Jen Catholic University, New Taipei City, Taiwan; Department of Applied Statistics and Information Science, Ming Chuan University, Taoyuan City, Taiwan.

出版信息

Asia Pac J Ophthalmol (Phila). 2024 May-Jun;13(3):100071. doi: 10.1016/j.apjo.2024.100071. Epub 2024 May 19.

DOI:10.1016/j.apjo.2024.100071
PMID:38768659
Abstract

AIMS

This study investigated the association between the frequency of screening for diabetic retinopathy (DR) versus the development of DR and corresponding medical expenses among patients newly diagnosed with type 2 diabetes mellitus (T2DM).

METHODS

This longitudinal, population-based study used the Taiwan National Health Insurance Research Database (2004 to 2020) as a data source. Propensity score matching (PSM) (sex, age, comorbidities and concurrent medication use) was employed in the grouping of T2DM patients according to different frequency of DR screening. Outcome measures included the proportion of patients who developed DR, who received DR treatment, and the associated medical expenses and hospitalizations.

RESULTS

The 17-year cohort included 337,046 patients. After PSM, three groups each containing 35,739 patients were assembled and analyzed. Compared to low-frequency screening, high-frequency screening was more effective in detecting patients requiring treatment; however, the net cost for treatment was significantly lower. Standard-frequency screening appears to provide the best balance in terms of DR detection, diagnosis interval, the risk of DR-related hospitalization, and DR treatment costs.

CONCLUSIONS

In this real-world cohort study covering all levels of the healthcare system, infrequent screening was associated with delayed diagnosis and elevated treatment costs, while a fundus screening interval of 1-2 years proved optimal in terms of detection and medical expenditures.

摘要

目的

本研究旨在探讨 2 型糖尿病(T2DM)新诊断患者中糖尿病视网膜病变(DR)筛查频率与 DR 发生发展及相应医疗费用之间的关系。

方法

本纵向、基于人群的研究使用了台湾全民健康保险研究数据库(2004 年至 2020 年)作为数据来源。根据 DR 筛查频率的不同,采用倾向评分匹配(PSM)(性别、年龄、合并症和同时使用的药物)对 T2DM 患者进行分组。结局指标包括发生 DR、接受 DR 治疗以及相关医疗费用和住院的患者比例。

结果

该 17 年队列包括 337046 名患者。经过 PSM 后,每组各包含 35739 名患者的三组被组装并进行了分析。与低频筛查相比,高频筛查更有效地发现需要治疗的患者;然而,治疗的净费用显著降低。标准频率筛查在 DR 检测、诊断间隔、DR 相关住院风险和 DR 治疗费用方面似乎提供了最佳的平衡。

结论

在涵盖各级医疗保健系统的真实世界队列研究中,不频繁的筛查与延迟诊断和治疗费用升高有关,而 1-2 年的眼底筛查间隔在检测和医疗支出方面被证明是最佳的。

相似文献

1
Cost-effectiveness of diabetic retinopathy screening for newly diagnosed type 2 diabetic patients: A nationwide population-based propensity score-matched cohort study.糖尿病视网膜病变筛查对新诊断 2 型糖尿病患者的成本效益:一项全国范围内基于倾向评分匹配队列研究。
Asia Pac J Ophthalmol (Phila). 2024 May-Jun;13(3):100071. doi: 10.1016/j.apjo.2024.100071. Epub 2024 May 19.
2
Early Screening for Diabetic Retinopathy in Newly Diagnosed Type 2 Diabetes and Its Effectiveness in Terms of Morbidity and Clinical Treatment: A Nationwide Population-Based Cohort.新发 2 型糖尿病患者的糖尿病视网膜病变早期筛查及其对发病率和临床治疗的影响:一项全国性基于人群的队列研究。
Front Public Health. 2022 Apr 26;10:771862. doi: 10.3389/fpubh.2022.771862. eCollection 2022.
3
Rates of Eye Care and Diabetic Eye Disease among Insured Patients with Newly Diagnosed Type 2 Diabetes.有新诊断 2 型糖尿病的参保患者的眼科保健和糖尿病眼病发生率。
Ophthalmol Retina. 2021 Feb;5(2):160-168. doi: 10.1016/j.oret.2020.07.004. Epub 2020 Jul 9.
4
Cost-effectiveness of a National Telemedicine Diabetic Retinopathy Screening Program in Singapore.新加坡国家远程医疗糖尿病视网膜病变筛查计划的成本效益分析。
Ophthalmology. 2016 Dec;123(12):2571-2580. doi: 10.1016/j.ophtha.2016.08.021. Epub 2016 Oct 7.
5
Economic evaluation of screening for diabetic retinopathy among Chinese type 2 diabetics: a community-based study in Kinmen, Taiwan.中国2型糖尿病患者糖尿病视网膜病变筛查的经济学评价:台湾金门一项基于社区的研究
J Epidemiol. 2008;18(5):225-33. doi: 10.2188/jea.je2007439. Epub 2008 Sep 8.
6
Evaluation of telemedicine for screening of diabetic retinopathy in the Veterans Health Administration.评估退伍军人健康管理局的远程医疗在糖尿病视网膜病变筛查中的应用。
Ophthalmology. 2013 Dec;120(12):2604-2610. doi: 10.1016/j.ophtha.2013.06.029. Epub 2013 Sep 29.
7
Strategies to Screen for Diabetic Retinopathy in Chinese Patients with Newly Diagnosed Type 2 Diabetes: A Cost-Effectiveness Analysis.中国新诊断2型糖尿病患者糖尿病视网膜病变筛查策略:一项成本效益分析
Medicine (Baltimore). 2015 Nov;94(45):e1989. doi: 10.1097/MD.0000000000001989.
8
Association of Primary Open-Angle Glaucoma with Diabetic Retinopathy among Patients with Type 1 and Type 2 Diabetes: A Large Global Database Study.1 型和 2 型糖尿病患者原发性开角型青光眼与糖尿病视网膜病变的相关性:一项大型全球数据库研究。
Ophthalmology. 2024 Jul;131(7):827-835. doi: 10.1016/j.ophtha.2024.01.016. Epub 2024 Jan 10.
9
Incidence and Risk Factors for Developing Diabetic Retinopathy among Youths with Type 1 or Type 2 Diabetes throughout the United States.美国1型或2型糖尿病青少年发生糖尿病视网膜病变的发病率及危险因素
Ophthalmology. 2017 Apr;124(4):424-430. doi: 10.1016/j.ophtha.2016.10.031. Epub 2016 Nov 30.
10
A health economic pilot study comparing two diabetic retinopathy screening strategies.一项健康经济学试点研究比较了两种糖尿病视网膜病变筛查策略。
Sci Rep. 2024 Jul 6;14(1):15618. doi: 10.1038/s41598-024-66405-2.

引用本文的文献

1
Vulnerable parafoveal microcirculation quadrant in patients with type 2 diabetes mellitus.2型糖尿病患者的易损性黄斑旁微循环象限
Sci Rep. 2025 Jan 7;15(1):1237. doi: 10.1038/s41598-024-85021-8.
2
The application of artificial intelligence in diabetic retinopathy: progress and prospects.人工智能在糖尿病视网膜病变中的应用:进展与展望。
Front Cell Dev Biol. 2024 Oct 25;12:1473176. doi: 10.3389/fcell.2024.1473176. eCollection 2024.